Ratios in Focus: Analyzing Perspective Therapeutics Inc (CATX)’s Price-to-Cash and Price-to-Free Cash Flow

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Perspective Therapeutics Inc (AMEX: CATX) closed at $11.09 down -1.42% from its previous closing price of $11.25. In other words, the price has decreased by -$1.42 from its previous closing price. On the day, 0.54 million shares were traded. CATX stock price reached its highest trading level at $11.6882 during the session, while it also had its lowest trading level at $11.04.

Ratios:

For a deeper understanding of Perspective Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 27.73 and its Current Ratio is at 27.73. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 24, 2024, initiated with a Buy rating and assigned the stock a target price of $20.

On October 01, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $25.

On September 25, 2024, Truist started tracking the stock assigning a Buy rating and target price of $21.Truist initiated its Buy rating on September 25, 2024, with a $21 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 12 ’24 when Mark Austin bought 2,500 shares for $15.80 per share.

Hunt Jonathan Robert bought 1,800 shares of CATX for $17,667 on Jun 17 ’24. The Chief Financial Officer now owns 35,971 shares after completing the transaction at $9.81 per share. On Jun 14 ’24, another insider, Woods Lori A, who serves as the Director of the company, bought 4,587 shares for $10.90 each. As a result, the insider paid 49,990 and bolstered with 159,985 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CATX now has a Market Capitalization of 747773184 and an Enterprise Value of 469567264. For the stock, the TTM Price-to-Sale (P/S) ratio is 80.78 while its Price-to-Book (P/B) ratio in mrq is 2.19. Its current Enterprise Value per Revenue stands at 320.743 whereas that against EBITDA is -9.934.

Stock Price History:

Over the past 52 weeks, CATX has reached a high of $19.05, while it has fallen to a 52-week low of $2.20. The 50-Day Moving Average of the stock is -14.68%, while the 200-Day Moving Average is calculated to be -13.28%.

Shares Statistics:

For the past three months, CATX has traded an average of 866.02K shares per day and 612190 over the past ten days. A total of 67.43M shares are outstanding, with a floating share count of 48.31M. Insiders hold about 28.35% of the company’s shares, while institutions hold 70.32% stake in the company. Shares short for CATX as of 1728950400 were 7881299 with a Short Ratio of 9.10, compared to 1726185600 on 7141541. Therefore, it implies a Short% of Shares Outstanding of 7881299 and a Short% of Float of 14.23.

Most Popular